Clinical Trial Update: Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on solitary islet transplantation for Type 1 diabetes using steroid-sparing immunosuppression, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus Type 1 | Phase 2 | Status: COMPLETED